BIOMAT Database Logo BIOMAT Database Logo

Naturally occurring structural isomers in serum IgA1 o-glycosylation. 2012

Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
UAB Biomedical FT-ICR MS Laboratory, MCLM 570, 1530 3rd Avenue South, Birmingham, AL 35294, USA.

IgA is the most abundantly produced antibody and plays an important role in the mucosal immune system. Human IgA is represented by two isotypes, IgA1 and IgA2. The major structural difference between these two subclasses is the presence of nine potential sites of O-glycosylation in the hinge region between the first and second constant region domains of the heavy chain. Thr(225), Thr(228), Ser(230), Ser(232) and Thr(236) have been identified as the predominant sites of O-glycan attachment. The range and distribution of O-glycan chains at each site within the context of adjacent sites in this clustered region create a complex heterogeneity of surface epitopes that is incompletely defined. We previously described the analysis of IgA1 O-glycan heterogeneity by use of high resolution LC-MS and electron capture dissociation tandem MS to unambiguously localize all amino acid attachment sites in IgA1 (Ale) myeloma protein. Here, we report the identification and elucidation of IgA1 O-glycopeptide structural isomers that occur based on amino acid position of the attached glycans (positional isomers) and the structure of the O-glycan chains at individual sites (glycan isomers). These isomers are present in a model IgA1 (Mce1) myeloma protein and occur naturally in normal human serum IgA1. Variable O-glycan chains attached to Ser(230), Thr(233) or Thr(236) produce the predominant positional isomers, including O-glycans composed of a single GalNAc residue. These findings represent the first definitive identification of structural isomeric IgA1 O-glycoforms, define the single-site heterogeneity for all O-glycan sites in a single sample, and have implications for defining epitopes based on clustered O-glycan variability.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009194 Myeloma Proteins Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA. M Components,Proteins, Myeloma
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
O-linked glycosylation in maize-expressed human IgA1.
October 2005, Glycobiology,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
December 2006, Journal of the American Society of Nephrology : JASN,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.
February 2017, PLoS genetics,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
Naturally occurring isomers of a bacterial menaquinone.
October 1967, Archives of biochemistry and biophysics,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
Naturally Occurring Follicle-Stimulating Hormone Glycosylation Variants.
January 2014, Journal of glycomics & lipidomics,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
Glycosylation of recombinant chimeric and human serum IgA1.
May 1992, Biochemical Society transactions,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
IgA1 desialylated by microbial neuraminidase forms immune complex with naturally occurring anti-T antibody in human serum.
January 2008, Immunology letters,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
January 2018, Kidney & blood pressure research,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
Heterogeneity of O-glycosylation in the hinge region of human IgA1.
December 2000, Molecular immunology,
Kazuo Takahashi, and Archer D Smith, and Knud Poulsen, and Mogens Kilian, and Bruce A Julian, and Jiri Mestecky, and Jan Novak, and Matthew B Renfrow
Oligomeric proanthocyanidins: naturally occurring O-heterocycles.
April 2000, Natural product reports,
Copied contents to your clipboard!